柠檬酸对分化型甲状腺癌患者首次131I治疗后唾液腺功能的保护作用

doi:10.13481/j.1671-587x.20190429

摘要/Abstract

摘要： 目的：探讨柠檬酸对术后首次行¹³¹I治疗（简称清甲治疗）的分化型甲状腺癌（DTC）患者唾液腺功能的影响，阐明柠檬酸对¹³¹I治疗的甲状腺癌患者唾液腺功能的保护作用。方法：经患者知情同意，随机选择准备首次行¹³¹I治疗的68例甲状腺乳头状癌患者，随机分为对照组和柠檬酸组，每组34例。对照组患者无特殊准备，柠檬酸组患者于¹³¹I治疗前1周及治疗后3周内每天含柠檬酸1 min（0.2 g/次）后吐出。2组患者分别于¹³¹I治疗前24 h及¹³¹I治疗后3个月行2次^99mTcO⁴^-唾液腺显像检查，计算第15分钟摄取指数（15 min UI）和排泌分数（SR），评估唾液腺功能。结果：与¹³¹I治疗前比较，对照组患者¹³¹I治疗后右侧腮腺和双侧颌下腺15 min UI差异无统计学意义（P>0.05），左侧腮腺15 min UI降低（P<0.05）；与¹³¹I治疗前比较，柠檬酸组患者¹³¹I治疗后双侧腮腺及双侧颌下腺15 min UI差异无统计学意义（P>0.05）；与对照组比较，柠檬酸组患者¹³¹I治疗前后双侧腮腺和双侧颌下腺15 min UI差异均无统计学意义（P>0.05）。与¹³¹I治疗前比较，对照组患者双侧腮腺治疗后SR降低（P<0.05），双侧颌下腺SR差异无统计学意义（P>0.05），柠檬酸组患者双侧腮腺和双侧颌下腺治疗后SR差异无统计学意义（P>0.05）；与对照组¹³¹I治疗后比较，柠檬酸组患者双侧腮腺SR升高（P<0.05），双侧颌下腺SR差异无统计学意义（P>0.05）。结论：DTC患者术后首次¹³¹I治疗后唾液腺排泌功能可能受损，短期口含柠檬酸对唾液腺具有保护作用，可以减轻唾液腺的放射性损伤。

关键词: 甲状腺肿瘤, 唾液腺, 碘131, 柠檬酸

Abstract: Objective:To investigate the effect of citric acid on the salivary gland function in the patients with differentiated thyroid cancer who received ¹³¹I treatment for the first time after operation, and to clarify the protective effect of citric acid on the salivary gland function in the patients with thyroid cancer who received¹³¹Itreatment. Methods:With the informed consent of the patients, 68 patients with thyroid papillary carcinoma who were going to receive ¹³¹I treatment were randomly selected and divided into control group and citric acid group (n=34). There was no special preparation for the patients in control group, and the patients in citric acid group kept citric acid in the mouth for 1 min and spit it out every day (0.2 g/time) at 1 week before and 3 weeks after ¹³¹I treatment. The patients in two groups received ^99mTcO⁴^- salivary gland imaging twice within 24 h before ¹³¹I treatment and 3 months after ¹³¹I treatment. The uptake index in the fifteenth minute (15 min UI) and the secretion ratio (SR) were calculated and the salivary gland function was evaluated. Results:Compared with before ¹³¹I treatment, the 15 min UI of the right parotid gland and bilateral submandibular glands of the patients in control group after treatment had no significant differences(P>0.05); the 15 min UI of left parotid gland after treatment was slightly decreased(P<0.05);compared with before ¹³¹I treatment, the 15 min UI of the bilateral parotid glands and bilateral submandibular glands of the patients in citric acid group had no significant differences(P>0.05). Compared with control group, the 15 min UI of bilateral parotid glands and bilateral submandibular glands of the patients in citric acid group before and after treatment had no significant differences(P>0.05). Compared with before ¹³¹I treatment, the SR of bilateral parotid glands of the patients in control group after treatment were decreased (P<0.05), and there were no differences in the SR of bilateral submaxillary glands after treatment(P>0.05). Compared with before ¹³¹I treatment, the SR of bilateral parotid glands and bilateral submandibular glands of the patients in citric group after treatment had no significant differences(P>0.05). The SR of bilateral parotid glands of the patients in citric acid group after treatment were higher than those in control group (P<0.05), but there were no significant differences in the SR of bilateral submandibular glands of the patients between two groups after treatment (P>0.05). Conclusion:First ¹³¹I treatment may cause the damage of the secretion function of the salivary glands in the DTC patients after operation. Short-term administration of citric acid in the mouth can protect the salivary glands and alleviate the radioactive injury of the salivary glands.

Key words: thyroid neoplasms, salivary glands, ¹³¹I, citric acid

中图分类号:

R736.1

王琦, 萨日, 林秋玉, 赵红光. 柠檬酸对分化型甲状腺癌患者首次¹³¹I治疗后唾液腺功能的保护作用[J]. 吉林大学学报(医学版), 2019, 45(04): 911-915.

WANG Qi, SA Ri, LIN Qiuyu, ZHAO Hongguang. Protective effect of citric acid on salivary gland function in patients with differentiated thyroid cancer after first ¹³¹I treatment[J]. Journal of Jilin University(Medicine Edition), 2019, 45(04): 911-915.

参考文献

[1] WU J Q, FENG H J, OUYANG W, et al. Systematic evaluation of salivary gland damage following I-131 therapy in differentiated thyroid cancer patients by quantitative scintigraphy and clinical follow-up[J]. Nucl Med Commun, 2015, 36(8):819-826.
[2] SAVAGE M W, SOBEL R K, HOFFMAN H T, et al. Salivary gland dysfunction and nasolacrimal duct obstruction:stenotic changes following I-131 therapy[J]. Ophthalmic Plast Reconstr Surg, 2015, 31(3):e50-e52.
[3] ALBANO D, BERTAGNA F, PANAROTTO M B, et al. Early and late adverse effects of radioiodine for pediatric differentiated thyroid cancer[J]. Pediatr Blood Cancer, 2017, 64(11):e26595.
[4] ISH-SHALOM S, DURLESHTER L, SEGAL E, et al. Sialochemical and oxidative analyses in radioactive I-131-treated patients with thyroid carcinoma[J]. Eur J Endocrinol, 2008, 158(5):677-681.
[5] FALLAHI B, BEIKI D, ABEDI S M, et al. Does vitamin E protect salivary glands from I-131 radiation damage in patients with thyroid cancer?[J]. Nucl Med Commun, 2013, 34(8):777-786.
[6] NAKAYAMA M, OKIZAKI A, TAKAHASHI K. A randomized controlled trial for the effectiveness of aromatherapy in decreasing salivary gland damage following radioactive iodine therapy for differentiated thyroid cancer[J]. Biomed Res Int, 2016,2016:9509810.
[7] KESSLER A T, BHATT A A. Review of the major and minor salivary glands, part 1:anatomy, infectious, and inflammatory processes[J]. J Clin Imaging Sci, 2018, 8:47.
[8] LI Y,TAYLOR J M,TEN HAKEN R K,et al.The impact of dose on parotid salivary recovery in head and neck cancer patients treated with radiation therapy[J].Int J Radiat Oncol Biol Phys, 2007, 67(3):660-669.
[9] 文静, 高沁怡, 李亚明, 等. 分化型甲状腺癌患者¹³¹I治疗前后唾液腺功能的变化[J]. 中国医学影像技术, 2010, 26(8):1553-1556.
[10] CHARALAMBOUS A. Seeking optimal management for radioactive iodine therapy-induced adverse effects[J]. Asia Pac J Oncol Nurs, 2017, 4(4):319-322.
[11] MARUOKA Y, BABA S, ISODA T, et al. A functional scoring system based on salivary gland scintigraphy for evaluating salivary gland dysfunction secondary to ¹³¹I therapy in patients with differentiated thyroid carcinoma[J]. J Clin Diagn Res, 2017, 11(8):TC23-TC28.
[12] 许杰华, 程木华, 苏宇雄, 等. 改良半定量唾液腺动态显像分析腮腺功能方法初探[J]. 中国医学影像学杂志, 2008, 16(5):344-347.
[13] 李林. 分化型甲状腺癌¹³¹I治疗:综合评估患者获益和风险[J].中华核医学与分子影像杂志, 2016, 36(5):381-383.
[14] DANIEL F I, LIMA L D, GRANDO L J, et al. Salivary evaluation in radioactive ¹³¹I treated patients with thyroid carcinoma[J]. Acta Odontol Scand, 2018, 76(2):148-152.
[15] 何静,程义壮,刘学公. ¹³¹I治疗分化型甲状腺癌引起唾液腺损伤的研究进展[J]. 中华现代护理杂志, 2012, 18(25):3076-3078.
[16] UPADHYAYA A, ZHOU PP, MENG ZW, et al. Radioprotective effect of vitamin E on salivary glands after radioiodine therapy for differentiated thyroid cancer:A randomized-controlled trial[J]. Nucl Med Commun, 2017, 38(11):891-903.
[17] SON H, LEE S M, YOON R G, et al. Effect of selenium supplementation for protection of salivary glands from iodine-131 radiation damage in patients with differentiated thyroid cancer[J]. Hell J Nucl Med, 2017, 20(1):62-70.
[18] UPADHYAYA A, MENG ZW, WANG P, et al. Effects of first radioiodine ablation on functions of salivary glands in patients with differentiated thyroid cancer[J]. Medicine (Baltimore), 2017, 96(25):e7164.
[19] HAGHIGHATAFSHAR M, NOWSHAD R, ETEMADI Z, et al. The effect of chewing-gum on dose rate of salivary gland in differentiated thyroid carcinoma patients treated with radioiodine[J]. Q J Nucl Med Mol Imaging, 2018. DOI:10.23736/S1824-4785.18.03078-9.
[20] 王澎, 孟召伟, 谭建, 等. 维生素E对术后首次行¹³¹I治疗的分化型甲状腺癌患者唾液腺功能的保护作用[J]. 中华核医学与分子影像杂志, 2016, 36(5):398-401.

柠檬酸对分化型甲状腺癌患者首次¹³¹I治疗后唾液腺功能的保护作用

Protective effect of citric acid on salivary gland function in patients with differentiated thyroid cancer after first ¹³¹I treatment

RichHTML

PDF (PC)

赞

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

Metrics

本文评价

推荐阅读 0

[1]	黑利娟, 王娟红, 魏威, 方航荣, 段瑛, 马士芬, 徐俊荣. 乳头状甲状腺癌患者血清和甲状腺组织中白细胞介素6水平的检测及其意义[J]. 吉林大学学报(医学版), 2019, 45(03): 601-605.
[2]	魏佳, 王瑶琪, 孙旭, 逄仁柱, 杨帅, 石亮, 李勇, 孟宪瑛. 甲状腺癌相关基因及其在临床诊断中应用的研究进展[J]. 吉林大学学报(医学版), 2018, 44(04): 880-885.
[3]	马晓周, 刘麒麟, 尹唯凰, 王越, 于阳, 杨刚, 于子莹. CC趋化因子受体6在人唾液腺腺样囊性癌组织中的表达及其临床意义[J]. 吉林大学学报(医学版), 2018, 44(01): 147-150.
[4]	赵朋, 付彤, 张秀祥, 战越, 关欣, 石爱平. 乳腺癌伴甲状腺癌和皮肌炎1例报告及3种疾病关联性文献复习[J]. 吉林大学学报(医学版), 2017, 43(05): 1015-1018.
[5]	张亚敏, 朱慧勇. 唾液腺干细胞及其在放射性唾液腺损伤治疗中应用的研究进展[J]. 吉林大学学报(医学版), 2017, 43(04): 852-856.
[6]	刘瑞东, 付彤, 韩冰, 董丙飞, 孟伟, 宋东. 侧方异位甲状腺1例报告及文献复习[J]. 吉林大学学报(医学版), 2017, 43(03): 640-642.
[7]	徐烁, 孟宪瑛, 逄仁柱, 杨帅, 韩佳滨, 孙旭, 朱继红. Ki-67和BRAF基因突变与甲状腺乳头状癌侵袭性关系的研究进展[J]. 吉林大学学报(医学版), 2016, 42(06): 1259-1262.
[8]	赵民学，李柏文，朱琳，叶洪珊，田晓丰，魏亮，曹宏. 甲状腺乳头状癌患者肿瘤组织和血清中miR-21表达水平检测及其意义[J]. 吉林大学学报(医学版), 2014, 40(06): 1237-1240.
[9]	吴文芳,邱金旭,卢丽敏,杨冬艳 . 甲状腺乳头状癌并发颈部淋巴结结核的超声影像学特征[J]. 吉林大学学报(医学版), 2014, 40(04): 895-897.
[10]	孙明玉，李明，刘守军 . 碘摄入量与甲状腺癌关系的研究进展[J]. 吉林大学学报(医学版), 2013, 39(4): 847-850.
[11]	王崇，刘晓莉，史杰萍，吴燕华，王诗镔,于雅琴，孙辉. RET基因多态性与甲状腺乳头状癌的关联性分析[J]. 吉林大学学报(医学版), 2013, 39(2): 322-325.
[12]	贺梦子，赵银龙，刘晓冬，马淑梅，刘欣. 甲状腺乳头状癌组织中差异表达miRNA及其靶基因的筛选和预测[J]. 吉林大学学报(医学版), 2013, 39(1): 99-103.
[13]	孙亚东\|张景斌\|杨乐\|马彦\|姜春浩\| 邸军 . 实时荧光定量PCR法检测EG-1在甲状腺乳头状癌组织中的表达及其临床意义[J]. J4, 2012, 38(5): 981-984.
[14]	李新白\|孟宪瑛\|王广义\|张强\|李群. 塞来昔布对人甲状腺髓样癌TT细胞中VEGF和MMP-9表达的抑制作用及其机制[J]. J4, 2012, 38(3): 543-546.
[15]	于鹏\|宫凤玲\|梁永平\|王荣福\|张建华. 分化型甲状腺癌清甲治疗后¹³¹I全身显像与甲状腺球蛋白检测结果的相关性分析[J]. J4, 2011, 37(4): 691-694.